These results suggest that overexpression of PLAC1 results in increased interaction of these cells with the activating receptors NKG2D, DNAM1, NKp30, and NKp44, potentially amplifying the recognition and lysis of tumor cells by NK cells. Here, CD226 is linked to neoplasm.